What Researchers Did
Researchers presented a case report of a 56-year-old Chinese man with acute atherosclerotic ischemic stroke who received hyperbaric oxygen therapy (HBO2T) after being ineligible for thrombolytic treatment.
What They Found
The 56-year-old patient, who presented with right hemiparesis and dysarthria, experienced great improvement after a course of HBO2T. This improvement was evaluated using standard stroke rating scales and cerebral perfusion images, including brain-computed tomography perfusion and single-photon emission computed tomography.
What This Means for Canadian Patients
This case report suggests that HBO2T could be a potential alternative or additional treatment for Canadian patients with ischemic stroke, especially when thrombolytic therapy is not an option. However, more research is needed before it can be widely recommended.
Canadian Relevance
This study has no direct Canadian connection as it is a case report from a Chinese patient and does not involve Canadian researchers or institutions.
Study Limitations
As a single case report, the findings cannot be generalized to a broader patient population, and further large-scale clinical trials are needed.